Smart Insulin Pens Market Share, Trends, Revenue, Growth Drivers, Key Players, Business Challenges, Opportunities and Future Competition Till 2033


Smart Insulin Pens Market Share, Trends, Revenue, Growth Drivers, Key Players, Business Challenges, Opportunities and Future Competition Till 2033: SPER Market Research

 Category : Healthcare

 Published: Apr-2024
 Author: SPER Analyst

Smart Insulin Pens Market is projected to be worth USD 2054.11 million by 2033 and is anticipated to surge at a CAGR of 10.69%.

An efficient way for diabetic individuals to manage their insulin delivery is through the use of a smartphone app and reusable injector pen called a "smart insulin pen." By pairing these "second-generation" pens with Bluetooth or USB, one can send data wirelessly to app. Compared to conventional insulin, it is less expensive, simpler to use, and offers useful data, alerts, and reminders. It aids in the calculation of meal sizes, active insulin dosages, blood sugar levels, and carbohydrate amounts. It also alerts about the insulin cartridge's expiration date and temperature range exceedingly so can be replaced on time. Consequently, smart insulin pens are widely used in ambulatory surgical centers, clinics, hospitals, and home care units all over the world.

Global Smart Insulin Pens Market Driving Factors and Challenges
The main driving force behind smart insulin pens is their high dose calculation accuracy, which leads to better clinical outcomes in diabetic patients. Through reminders and conventional glucose monitoring, these pens help patients stick to their prescribed insulin dose, leading to better diabetes self-management. Moreover, the availability of many diabetes-related therapies motivates patients to use connected insulin pens and auto-injectors for self-management. As smart insulin pens proceed down the path of digitization, the user can expect further advantages such enhanced decision support, artificial intelligence (AI), and iterative software development. Future care delivery models that rely on asynchronous interaction-based technology advancements and open, smooth, and continuous data interchange across the growing number of diabetes devices will be dependent on these innovations.

An important obstacle for the global market for smart insulin pens in coming years may be the high price of these devices as well as other diabetes treatment alternatives. Patients are discouraged from seeking treatment in underdeveloped areas due to inadequate healthcare facilities and unfavourable reimbursement conditions. The availability of alternatives like painless smart insulin patches is predicted to impede market expansion as well. Wearable insulin patches enable for more discrete insulin dosage throughout the day, offering injection-free insulin delivery as needed, hence keeping blood sugar levels stable. The patch works faster than an insulin pen, is easier to use, and is comprised of biocompatible materials.

Impact of COVID-19 on Global Smart Insulin Pens Market
A lack of vital medical supplies, including smart insulin pens, resulted from the COVID 19 outbreak and the lockdown that followed, which had an impact on manufacturing procedures. The patients' inability to obtain the product was exacerbated by a decrease in production and a spike in delivery time. However, because diabetic people were more susceptible to problems, insulin management had become crucial for controlling blood sugar levels. Therefore, use of smart insulin pens increased, which decreased the number of hospital admissions. Additionally, the inclination for homecare settings also served as a fuel for growth in the e-commerce sales of smart insulin pens. 

Global Smart Insulin Pens Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as Bigfoot Biomedical, Diamesco Co. Ltd., Eli Lilly and Company, Emperra GmbH, Jiangsu Deflu Medical Device Co. Ltd., Medtronic plc, Novo Nordisk A/S, Pendiq, Sanofi (Sanofi-Aventis US LLC), Ypsomed Holding AG, and others.

Global Smart Insulin Pens Market Segmentation:

By Product: Based on the Product, Global Smart Insulin Pens Market is segmented as; Smart Insulin Pens, Adaptors for Conventional Pens

By Connectivity Type: Based on the Connectivity Type, Global Smart Insulin Pens Market is segmented as; Bluetooth, USB

By Application: Based on the Application, Global Smart Insulin Pens Market is segmented as; Type 1 Diabetes, Type 2 Diabetes

By Distribution Channel: Based on the Distribution Channel, Global Smart Insulin Pens Market is segmented as; Hospital Pharmacies, Online Sales, Retail Pharmacies, Diabetes Clinics/Centers

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe. 

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]